IRIS Accounts Production v24.3.2.46 07221246 Board of Directors 1.5.23 30.4.24 30.4.24 0 0 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072212462023-04-30072212462024-04-30072212462023-05-012024-04-30072212462022-04-30072212462022-05-012023-04-30072212462023-04-3007221246ns15:EnglandWales2023-05-012024-04-3007221246ns14:PoundSterling2023-05-012024-04-3007221246ns10:Director12023-05-012024-04-3007221246ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3007221246ns10:SmallEntities2023-05-012024-04-3007221246ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3007221246ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3007221246ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3007221246ns10:FullAccounts2023-05-012024-04-3007221246ns10:OrdinaryShareClass12023-05-012024-04-3007221246ns10:OrdinaryShareClass22023-05-012024-04-3007221246ns10:OrdinaryShareClass32023-05-012024-04-3007221246ns10:OrdinaryShareClass42023-05-012024-04-3007221246ns10:OrdinaryShareClass52023-05-012024-04-3007221246ns10:Director22023-05-012024-04-3007221246ns10:RegisteredOffice2023-05-012024-04-3007221246ns5:CurrentFinancialInstruments2024-04-3007221246ns5:CurrentFinancialInstruments2023-04-3007221246ns5:ShareCapital2024-04-3007221246ns5:ShareCapital2023-04-3007221246ns5:RetainedEarningsAccumulatedLosses2024-04-3007221246ns5:RetainedEarningsAccumulatedLosses2023-04-3007221246ns5:PlantMachinery2023-05-012024-04-3007221246ns5:PlantMachinery2023-04-3007221246ns5:PlantMachinery2024-04-3007221246ns5:PlantMachinery2023-04-3007221246ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3007221246ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3007221246ns5:DeferredTaxation2023-04-3007221246ns5:DeferredTaxation2024-04-3007221246ns10:OrdinaryShareClass12024-04-3007221246ns10:OrdinaryShareClass22024-04-3007221246ns10:OrdinaryShareClass32024-04-3007221246ns10:OrdinaryShareClass42024-04-3007221246ns10:OrdinaryShareClass52024-04-30
REGISTERED NUMBER: 07221246 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024

FOR

EAR & NOSE CARE LIMITED

EAR & NOSE CARE LIMITED (REGISTERED NUMBER: 07221246)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


EAR & NOSE CARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTORS: F F Fahmy
N F Guirguis





REGISTERED OFFICE: 10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA





BUSINESS ADDRESS: Danehill Farmhouse
Danehill Road
Kennett
Newmarket
Suffolk
CB8 7QX





REGISTERED NUMBER: 07221246 (England and Wales)





ACCOUNTANTS: Thompson Taraz Rand Ltd
Chartered Accountants
10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA

EAR & NOSE CARE LIMITED (REGISTERED NUMBER: 07221246)

BALANCE SHEET
30 APRIL 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 5 399 533

CURRENT ASSETS
Debtors 6 33,361 28,712
Cash at bank 34,294 44,346
67,655 73,058
CREDITORS
Amounts falling due within one year 7 (21,221 ) (38,784 )
NET CURRENT ASSETS 46,434 34,274
TOTAL ASSETS LESS CURRENT LIABILITIES 46,833 34,807

PROVISIONS FOR LIABILITIES 8 (76 ) (101 )
NET ASSETS 46,757 34,706

CAPITAL AND RESERVES
Called up share capital 9 8 8
Retained earnings 46,749 34,698
SHAREHOLDERS' FUNDS 46,757 34,706

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

EAR & NOSE CARE LIMITED (REGISTERED NUMBER: 07221246)

BALANCE SHEET - continued
30 APRIL 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 January 2025 and were signed on its behalf by:





F F Fahmy - Director


EAR & NOSE CARE LIMITED (REGISTERED NUMBER: 07221246)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

Ear & Nose Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover relates to services provided in respect of ear, nose and throat surgery. This is recognised by the completion of a sales invoice.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Financial instruments
Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Preparation of consolidated financial statements
The financial statements contain information about Ear & Nose Care Limited as an individual company and do not contain consolidated financial information as the parent of the group. The company has taken the option under Section 398 of the Companies Act 2006 not to prepare consolidated financial statements

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

EAR & NOSE CARE LIMITED (REGISTERED NUMBER: 07221246)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023
and 30 April 2024 20,582
DEPRECIATION
At 1 May 2023 20,049
Charge for year 134
At 30 April 2024 20,183
NET BOOK VALUE
At 30 April 2024 399
At 30 April 2023 533

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 18,784 28,712
Amounts owed by associates 14,577 -
33,361 28,712

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Amounts owed to associates - 17,229
Taxation and social security 15,973 17,712
Other creditors 5,248 3,843
21,221 38,784

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 76 101

Deferred
tax
£   
Balance at 1 May 2023 101
Movement in provision (25 )
Balance at 30 April 2024 76

EAR & NOSE CARE LIMITED (REGISTERED NUMBER: 07221246)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
3 Ordinary £1 3 3
1 Ordinary A £1 1 1
1 Ordinary B £1 1 1
1 Ordinary C £1 1 1
2 Ordinary D £1 2 2
8 8